Skip to main content
Erschienen in:

15.09.2017 | Original Article

Interleukin-17 as a predictor of sepsis in polytrauma patients: a prospective cohort study

verfasst von: M. Ahmed Ali, E. S. Mikhael, A. Abdelkader, L. Mansour, R. El Essawy, R. El Sayed, A. Eladawy, A. Mukhtar

Erschienen in: European Journal of Trauma and Emergency Surgery | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Sepsis is one of the most serious complications after major trauma, and may be associated with increased mortality. We sought to determine whether there is an association between serum levels of interleukin-17 (IL-17) at the time of admission to the intensive care unit (ICU) and the development of sepsis. We evaluated 100 adult patients with major trauma admitted to the surgical ICU over a 6-month period. Serum levels of IL-17, IL-6, and TNF-α were determined by enzyme-linked immunosorbent assays (ELISA). The IL-17 rs1974226 genotype was determined by real-time PCR. In both non-adjusted and adjusted analyses, IL-17 was the only biomarker significantly associated with sepsis [median serum IL-17 of 72 pg/mL in sepsis versus 37 pg/mL in those without sepsis, P = 0.0001; adjusted odds ratio (OR) 3.2, P = 0.02]. No significant association was found among IL-17 rs1974226 genotypes and related serum cytokine levels. These data suggest that elevated serum IL-17 may increase the susceptibility for septic complications in polytrauma patients and so could be a useful biomarker for trauma patient management.
Literatur
1.
Zurück zum Zitat Wang Z, Jiang J. An overview of research advances in road traffic trauma in China. Traffic Inj Prev. 2003;4(1):9–16.CrossRefPubMed Wang Z, Jiang J. An overview of research advances in road traffic trauma in China. Traffic Inj Prev. 2003;4(1):9–16.CrossRefPubMed
2.
Zurück zum Zitat Ciesla DJ, Moore EE, Johnson JL, Burch JM, Cothren CC, Sauaia A. A 12-year prospective study of postinjury multiple organ failure: has anything changed? Arch Surg. 2005;140(5):432–8.CrossRefPubMed Ciesla DJ, Moore EE, Johnson JL, Burch JM, Cothren CC, Sauaia A. A 12-year prospective study of postinjury multiple organ failure: has anything changed? Arch Surg. 2005;140(5):432–8.CrossRefPubMed
3.
Zurück zum Zitat Moore FA, Moore EE. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin N Am. 1995;75(2):257–77.CrossRefPubMed Moore FA, Moore EE. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin N Am. 1995;75(2):257–77.CrossRefPubMed
5.
Zurück zum Zitat Ward NS, Casserly B, Ayala A. The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med. 2008;29(4):617–25.CrossRefPubMedPubMedCentral Ward NS, Casserly B, Ayala A. The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med. 2008;29(4):617–25.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional specialization of interleukin-17 family members. Immunity. 2011;34(2):149–62.CrossRefPubMed Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional specialization of interleukin-17 family members. Immunity. 2011;34(2):149–62.CrossRefPubMed
7.
Zurück zum Zitat Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med. 2008;36(3):941–52.CrossRefPubMed Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med. 2008;36(3):941–52.CrossRefPubMed
8.
Zurück zum Zitat Dominguez-Villar M, Hafler D a. Immunology. An innate role for IL-17. Science. 2011;332(6025):47–8.CrossRefPubMed Dominguez-Villar M, Hafler D a. Immunology. An innate role for IL-17. Science. 2011;332(6025):47–8.CrossRefPubMed
9.
Zurück zum Zitat Schwarzenberger P, Huang W, Ye P, Oliver P, Manuel M, Zhang Z, Bagby G, Nelson S, Kolls JK. Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J Immunol. 2000;164(9):4783–9.CrossRefPubMed Schwarzenberger P, Huang W, Ye P, Oliver P, Manuel M, Zhang Z, Bagby G, Nelson S, Kolls JK. Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J Immunol. 2000;164(9):4783–9.CrossRefPubMed
10.
Zurück zum Zitat Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101(6):1644–55.CrossRefPubMed Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101(6):1644–55.CrossRefPubMed
11.
Zurück zum Zitat Frangen TM, Bogdanski D, Schinkel C, Roetman B, Muhr G, Koller M. Systemic IL-17 after severe injuries. Shock. 2008;29(4):462–427.CrossRefPubMed Frangen TM, Bogdanski D, Schinkel C, Roetman B, Muhr G, Koller M. Systemic IL-17 after severe injuries. Shock. 2008;29(4):462–427.CrossRefPubMed
12.
Zurück zum Zitat Roy AK, Mc Gorrian C, Treacy C, Kavanaugh E, Brennan A, Mahon NG. A comparison of traditional and Novel definitions (RIFLE, AKIN, and KDIGO) of acute kidney injury for the prediction of outcomes in acute decompensated heart failure. Cardiorenal Med. 2013;3(1):26–37.CrossRefPubMedPubMedCentral Roy AK, Mc Gorrian C, Treacy C, Kavanaugh E, Brennan A, Mahon NG. A comparison of traditional and Novel definitions (RIFLE, AKIN, and KDIGO) of acute kidney injury for the prediction of outcomes in acute decompensated heart failure. Cardiorenal Med. 2013;3(1):26–37.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Acute respiratory distress syndrome: the Berlin Definition. JAMA, 307:2526–33, 2012. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Acute respiratory distress syndrome: the Berlin Definition. JAMA, 307:2526–33, 2012.
14.
Zurück zum Zitat Nieves E, Tobo LF, Beltra JA. Bacterial translocation in abdominal trauma and postoperative infections. J Trauma. 2011;71(63):1258–61.CrossRefPubMed Nieves E, Tobo LF, Beltra JA. Bacterial translocation in abdominal trauma and postoperative infections. J Trauma. 2011;71(63):1258–61.CrossRefPubMed
15.
Zurück zum Zitat Sebastian, Tranca. Cristina Petrișor, Natalia Hagau, Constantin Ciuce. Can APACHE II, SOFA, ISS, and RTS severity scores be used to predict septic complications in multiple trauma patients? JCCM. 2016;2(3):124–30. Sebastian, Tranca. Cristina Petrișor, Natalia Hagau, Constantin Ciuce. Can APACHE II, SOFA, ISS, and RTS severity scores be used to predict septic complications in multiple trauma patients? JCCM. 2016;2(3):124–30.
16.
Zurück zum Zitat Chunfang Gu Ling, Wua Xiaoxia, Li. IL-17 family: cytokines, receptors and signaling. Cytokine. 2013;64(2):1–9. Chunfang Gu Ling, Wua Xiaoxia, Li. IL-17 family: cytokines, receptors and signaling. Cytokine. 2013;64(2):1–9.
17.
Zurück zum Zitat Nakada TA, Russell JA, Boyd JH, Walley KR. IL17A genetic variation is associated with altered susceptibility to Gram-positive infection and mortality of severe sepsis. Crit Care. 15(5), 2011. Nakada TA, Russell JA, Boyd JH, Walley KR. IL17A genetic variation is associated with altered susceptibility to Gram-positive infection and mortality of severe sepsis. Crit Care. 15(5), 2011.
18.
Zurück zum Zitat Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol. 2010;10(7):479–89.CrossRefPubMed Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol. 2010;10(7):479–89.CrossRefPubMed
19.
Zurück zum Zitat Hashmi S, Zeng QT. Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease. Coron Artery Dis. 2006;17(8):699–706.CrossRefPubMed Hashmi S, Zeng QT. Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease. Coron Artery Dis. 2006;17(8):699–706.CrossRefPubMed
21.
Zurück zum Zitat Billeter A, Turina M, Seifert B, Mica L, Stocker R, Keel M. Early serum procalcitonin, interleukin-6, and 24-hour lactate clearance: useful indicators of septic infections in severely traumatized patients. World J Surg. 2009;33:558–66CrossRefPubMed Billeter A, Turina M, Seifert B, Mica L, Stocker R, Keel M. Early serum procalcitonin, interleukin-6, and 24-hour lactate clearance: useful indicators of septic infections in severely traumatized patients. World J Surg. 2009;33:558–66CrossRefPubMed
22.
Zurück zum Zitat Keel M, Harter L, Reding T, Sun LK, Hersberger M, Seifert B, et al. Pancreatic stone protein is highly increased during posttraumatic sepsis and activates neutrophil granulocytes. Crit Care Med. 2009;37:1642–8.CrossRefPubMed Keel M, Harter L, Reding T, Sun LK, Hersberger M, Seifert B, et al. Pancreatic stone protein is highly increased during posttraumatic sepsis and activates neutrophil granulocytes. Crit Care Med. 2009;37:1642–8.CrossRefPubMed
23.
Zurück zum Zitat Egger G, Aigner R, Glasner A, Hofer HP, Mitterhammer H, Zelzer S. Blood polymorphonuclear leukocyte migration as a predictive marker for infections in severe trauma: Comparison with various inflammation parameters. Intensive Care Med. 2004;30:331–4.CrossRefPubMed Egger G, Aigner R, Glasner A, Hofer HP, Mitterhammer H, Zelzer S. Blood polymorphonuclear leukocyte migration as a predictive marker for infections in severe trauma: Comparison with various inflammation parameters. Intensive Care Med. 2004;30:331–4.CrossRefPubMed
24.
Zurück zum Zitat Flores JM, Jimenez PI, Rincon MD, Marquez JA, Navarro H, Arteta D, et al. Early risk factors for sepsis in patients with severe blunt trauma. Injury. 2001;32:5–12.CrossRefPubMed Flores JM, Jimenez PI, Rincon MD, Marquez JA, Navarro H, Arteta D, et al. Early risk factors for sepsis in patients with severe blunt trauma. Injury. 2001;32:5–12.CrossRefPubMed
25.
Zurück zum Zitat Paunel-Gorgulu A, Flohe S, Scholz M, Windolf J, Logters T. Increased serum soluble Fas after major trauma is associated with delayed neutrophil apoptosis and development of sepsis. Crit Care. 2011;15:R20.CrossRefPubMedPubMedCentral Paunel-Gorgulu A, Flohe S, Scholz M, Windolf J, Logters T. Increased serum soluble Fas after major trauma is associated with delayed neutrophil apoptosis and development of sepsis. Crit Care. 2011;15:R20.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Giannoudis PV, Smith MR, Evans RT, Bellamy MC, Guillou PJ. Serum CRP and IL-6 levels after trauma. Not predictive of septic complications in 31 patients. Acta Orthop Scand. 1998;69:184–8.CrossRefPubMed Giannoudis PV, Smith MR, Evans RT, Bellamy MC, Guillou PJ. Serum CRP and IL-6 levels after trauma. Not predictive of septic complications in 31 patients. Acta Orthop Scand. 1998;69:184–8.CrossRefPubMed
27.
Zurück zum Zitat Giannoudis PV, Smith RM, Banks RE, Windsor AC, Dickson RA, Guillou PJ. Stimulation of inflammatory markers after blunt trauma. Br J Surg.1998;85:986–90CrossRefPubMed Giannoudis PV, Smith RM, Banks RE, Windsor AC, Dickson RA, Guillou PJ. Stimulation of inflammatory markers after blunt trauma. Br J Surg.1998;85:986–90CrossRefPubMed
28.
Zurück zum Zitat Giamarellos-Bourboulis EJ, Mouktaroudi M, Tsaganos T, Koutoukas P, Spyridaki E, Pelekanou A, et al. Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma. J Trauma. 2008;65:1385–90.CrossRefPubMed Giamarellos-Bourboulis EJ, Mouktaroudi M, Tsaganos T, Koutoukas P, Spyridaki E, Pelekanou A, et al. Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma. J Trauma. 2008;65:1385–90.CrossRefPubMed
29.
Zurück zum Zitat van Beelen AJ, Zelinkova Z, Taanman-Kueter EW, Muller FJ, Hommes DW, Zaat SA, Kapsenberg ML, de Jong EC. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity. 2007;27:660–9.CrossRefPubMed van Beelen AJ, Zelinkova Z, Taanman-Kueter EW, Muller FJ, Hommes DW, Zaat SA, Kapsenberg ML, de Jong EC. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity. 2007;27:660–9.CrossRefPubMed
30.
Zurück zum Zitat Niebuhr M, Gathmann M, Scharonow H, Mamerow D, Mommert S, Balaji H, Werfel T. Staphylococcal alpha-toxin is a strong inducer of interleukin-17 in humans. Infect Immun. 2011;79:1615–22.CrossRefPubMedPubMedCentral Niebuhr M, Gathmann M, Scharonow H, Mamerow D, Mommert S, Balaji H, Werfel T. Staphylococcal alpha-toxin is a strong inducer of interleukin-17 in humans. Infect Immun. 2011;79:1615–22.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Hagau N, Slavcovici A, Gonganau DN, Oltean S, Dirzu DS, Brezoszki ES, Maxim M, Ciuce C, Mlesnite M, Gavrus RL, Laslo C, Hagau R, Petrescu M, Studnicska DM. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit Care. 2010;14:R203.CrossRefPubMedPubMedCentral Hagau N, Slavcovici A, Gonganau DN, Oltean S, Dirzu DS, Brezoszki ES, Maxim M, Ciuce C, Mlesnite M, Gavrus RL, Laslo C, Hagau R, Petrescu M, Studnicska DM. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit Care. 2010;14:R203.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Cho JS, Pietras EM, Garcia NC, Ramos RI, Farzam DM, Monroe HR, Magorien JE, Blauvelt A, Kolls JK, Cheung AL, Cheng G, Modlin RL, Miller LS. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest. 2010;120:1762–73.CrossRefPubMedPubMedCentral Cho JS, Pietras EM, Garcia NC, Ramos RI, Farzam DM, Monroe HR, Magorien JE, Blauvelt A, Kolls JK, Cheung AL, Cheng G, Modlin RL, Miller LS. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest. 2010;120:1762–73.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Kagami S, Rizzo HL, Kurtz SE, Miller LS, Blauvelt A. IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J Immunol. 2010;185:5453–62.CrossRefPubMedPubMedCentral Kagami S, Rizzo HL, Kurtz SE, Miller LS, Blauvelt A. IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J Immunol. 2010;185:5453–62.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Ishigame H, Kakuta S, Nagai T, Kadoki M, Nambu A, Komiyama Y, Fujikado N, Tanahashi Y, Akitsu A, Kotaki H, Sudo K, Nakae S, Sasakawa C, Iwakura Y. Differential roles of interleukin-17A and – 17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity. 2009;30:108–19.CrossRefPubMed Ishigame H, Kakuta S, Nagai T, Kadoki M, Nambu A, Komiyama Y, Fujikado N, Tanahashi Y, Akitsu A, Kotaki H, Sudo K, Nakae S, Sasakawa C, Iwakura Y. Differential roles of interleukin-17A and – 17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity. 2009;30:108–19.CrossRefPubMed
35.
Zurück zum Zitat Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis. 2004;190:624–31.CrossRefPubMed Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis. 2004;190:624–31.CrossRefPubMed
36.
Zurück zum Zitat Saijo S, Ikeda S, Yamabe K, Kakuta S, Ishigame H, Akitsu A, Fujikado N, Kusaka T, Kubo S, Chung SH, Komatsu R, Miura N, Adachi Y, Ohno N, Shibuya K, Yamamoto N, Kawakami K, Yamasaki S, Saito T, Akira S, Iwakura Y. Dectin-2 recognition of alpha-mannans and induction of Th17cell differentiation is essential for host defense against Candida albicans. Immunity. 2010;32:681–91.CrossRefPubMed Saijo S, Ikeda S, Yamabe K, Kakuta S, Ishigame H, Akitsu A, Fujikado N, Kusaka T, Kubo S, Chung SH, Komatsu R, Miura N, Adachi Y, Ohno N, Shibuya K, Yamamoto N, Kawakami K, Yamasaki S, Saito T, Akira S, Iwakura Y. Dectin-2 recognition of alpha-mannans and induction of Th17cell differentiation is essential for host defense against Candida albicans. Immunity. 2010;32:681–91.CrossRefPubMed
37.
Zurück zum Zitat Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med. 2009;206:299–311.CrossRefPubMedPubMedCentral Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med. 2009;206:299–311.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Schelonka RL, Maheshwari A, Carlo WA, Taylor S, Hansen NI, Schendel DE, Thorsen P, Skogstrand K, Hougaard DM, Higgins RD. T cell cytokines and the risk of blood stream infection in extremely low birth weight infants. Cytokine. 2011;53:249–55.CrossRefPubMed Schelonka RL, Maheshwari A, Carlo WA, Taylor S, Hansen NI, Schendel DE, Thorsen P, Skogstrand K, Hougaard DM, Higgins RD. T cell cytokines and the risk of blood stream infection in extremely low birth weight infants. Cytokine. 2011;53:249–55.CrossRefPubMed
39.
Zurück zum Zitat Accardo Palumbo A, Forte GI, Pileri D, Vaccarino L, Conte F, D‘Amelio L, Palmeri M, Triolo A, D‘Arpa N, Scola L, Misiano G, Milano S, Lio D. Analysis of IL-6, IL-10 and IL-17 genetic polymorphisms as risk factors for sepsis development in burned patients. Burns. 2011;38(2):208–13.CrossRefPubMed Accardo Palumbo A, Forte GI, Pileri D, Vaccarino L, Conte F, D‘Amelio L, Palmeri M, Triolo A, D‘Arpa N, Scola L, Misiano G, Milano S, Lio D. Analysis of IL-6, IL-10 and IL-17 genetic polymorphisms as risk factors for sepsis development in burned patients. Burns. 2011;38(2):208–13.CrossRefPubMed
Metadaten
Titel
Interleukin-17 as a predictor of sepsis in polytrauma patients: a prospective cohort study
verfasst von
M. Ahmed Ali
E. S. Mikhael
A. Abdelkader
L. Mansour
R. El Essawy
R. El Sayed
A. Eladawy
A. Mukhtar
Publikationsdatum
15.09.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Trauma and Emergency Surgery / Ausgabe 4/2018
Print ISSN: 1863-9933
Elektronische ISSN: 1863-9941
DOI
https://doi.org/10.1007/s00068-017-0841-3

Weitere Artikel der Ausgabe 4/2018

European Journal of Trauma and Emergency Surgery 4/2018 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie erweitert durch Fallbeispiele, Videos und Abbildungen. Zur Fortbildung und Wissenserweiterung, verfasst und geprüft von Expertinnen und Experten der Gesellschaft für Arthroskopie und Gelenkchirurgie (AGA).


Jetzt entdecken!

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Morton-Neurom – besser Kortikoid oder Hyaluronsäure spritzen?

Dieser Vergleich hat einen klaren Ausgang: Forschende aus São Paulo haben die Wirkung ultraschallgesteuerter Kortikoidinjektionen gegen die Beschwerden des Morton-Neuroms mit den Effekten von Hyaluronsäureinjektionen verglichen. Das Fazit für die Praxis ist deutlich.

Morbus Dupuytren: Kollagenase-Injektion versus partielle Aponeurektomie

In der Behandlung von mittelschweren Dupuytren-Kontrakturen können Kollagenase-Injektionen von der Wirksamkeit her nicht mit der limitierten Aponeurektomie mithalten. Das hat der direkte Vergleich der beiden Methoden in der DISC-Studie ergeben.

Neue Osteoporose-Leitlinie: Frakturinzidenz senken, Versorgung verbessern

Das sind – zusammen mit dem Erhalt bzw. der Verbesserung der Funktionsfähigkeit und Lebensqualität der Patientinnen und Patienten – die Ziele der 2023er Leitlinie der Osteologischen Fachgesellschaften e.V. (DVO). Noch fremdeln viele Ärztinnen und Ärzte mit den neuen Konzepten und Risikotabellen. 

Myositiden – Fortschritte bei der Risikostratifizierung und Diagnostik

Bei der Myositis hat sich viel getan, was für den klinischen Alltag relevant ist – so Prof. Dr. Britta Maurer, Universitätsspital Bern, beim Deutschen Rheumatologiekongress 2024. Morbidität und Mortalität könnten zurückgehen.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.